Evidence map›Paper›PMID 41979156›Full record

ArticleJournal of applied clinical medical physics2026

Sensitivity and concordance study of an open source EPID-based linear accelerator test suite.

Lana C Critchfield, Cory S Knill, Ellie Durussel, Justin K Mikell, Michael Barnes, Michael Pillainayagam, William P Donahue, Seng Boh Lim, John J DeMarco, Mario Perez and 5 more

Abstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Lana C CritchfieldDepartment of Radiation Oncology, University of Michigan, Wyoming, Michigan, USA.
Cory S KnillDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.
Ellie DurusselDepartment of Radiation Oncology, University of Michigan, Essexville, Michigan, USA.
Justin K MikellDepartment of Radiation Oncology, Washington University, St. Louis, Missouri, USA.
Michael BarnesDepartment of Radiation Oncology, Calvary Mater Hospital Newcastle, NSW, Australia.ORCID https://orcid.org/0000-0003-0924-897X
Michael PillainayagamDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.
William P DonahueMemorial Sloan Kettering Cancer Center, Samford, Connecticut, USA.
Seng Boh LimRadiation Dosimetry Core, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.ORCID https://orcid.org/0000-0002-4054-8789
John J DeMarcoDepartment of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Mario PerezNorthern Sydney LHD, Sydney, NSW, Australia.
Nilendu GuptaDepartment of Radiation Oncology, The Ohio State University, James Cancer Hospital, Columbus, Ohio, USA.ORCID https://orcid.org/0000-0003-0461-0570
Hania Al-HallaqDepartment of Radiation Oncology, Emory University, Atlanta, Georgia, USA.
Richard A PoppleUniversity of Alabama Birmingham, Birmingham, Alabama, USA.ORCID https://orcid.org/0000-0003-1252-738X
Jim IrrerDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.
Jean M MoranMemorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID https://orcid.org/0000-0001-9668-7326

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748Varian Medical Systems AWD026105
6 · The paper itself

Abstract

backgroundElectronic portal imaging devices (EPIDs) enhance linear accelerator (linac) quality assurance (QA) efficiency but are not universally used beyond patient-specific IMRT QA. A multi-institutional Consortium seeks to standardize linac QA utilizing an EPID-based test suite. PURPOSE: This study evaluates the sensitivity of a test suite to intentional linac and plan errors and the concordance with linac fluctuations over time.

methodsBaseline and error-introduced tests were performed on a Varian TrueBeam and Clinac. Evaluated parameters included enhanced dynamic wedge factors (EDW) (6MV), central axis dose (6MV, 6MV FFF, 16MV), focal spot alignment and beam symmetry (6MV, 16MV), dose rate-gantry speed and multi-leaf collimator (MLC) leaf speed (6MV). Errors included varying EDW angles (10°-60°), output changes, beam steering for focal spot and symmetry inaccuracies, and meterset adjustments of control points for dose rate-gantry speed and MLC leaf speed tests. Measurements were performed with an EPID, analyzed via test suite software, and compared to an ion chamber (IC) or array. Concordance analysis was performed on a single linac over 5 months to assess the test suite's ability to quantify deviations during routine operations. Measurement reproducibility was assessed.

resultsResults were reported as differences between EPID and an IC or array. For each EDW, wedge factor differences were <0.5% (TrueBeam) and <1.5% (Clinac). Central axis dose variations stayed within ±0.8%. For focal spot, EPID underestimated the radial direction and overestimated the transverse direction. Symmetry measurements showed strong linearity (r > 0.99), though EPID measurements underestimated changes in symmetry relative to baseline. Maximum differences for dose rate-gantry speed and MLC leaf speed were <0.4%. In the concordance study, output differences averaged 0.3% ± 0.3% (6MV), 0.5% ± 0.3% (6MV FFF), and 0.3% ± 0.2% (16MV). Systematic differences in symmetry were observed between EPID and a 2D-array with standard deviations <0.2%.

conclusionsComparisons with traditional detectors showed the EPID test suite can detect errors and supports commissioning and clinical integration.

Indexed as

Particle AcceleratorsPhantoms, ImagingQuality Assurance, Health CareRadiometryRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedSoftwareHumansQuality ControlRadiotherapy DosageEPIDlinear acceleratorquality assurance

Identifiers

PMID41979156
PMCPMC13077667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.